Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-26T13:03:21.431Z Has data issue: false hasContentIssue false
  • English
  • Français

A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis

Published online by Cambridge University Press:  19 August 2014

Jashelle Caga ,
Eleanor Ramsey ,
Anne Hogden ,
Eneida Mioshi  and
Matthew C. Kiernan
Jashelle Caga*
Affiliation:
Neuroscience Research Australia, Randwick, New South Wales, Australia
Eleanor Ramsey
Affiliation:
Neuroscience Research Australia, Randwick, New South Wales, Australia
Anne Hogden
Affiliation:
Centre for Clinical Governance Research, Australian Institute of Health Innovation, University of New South Wales, Randwick, New South Wales, Australia
Eneida Mioshi
Affiliation:
Neuroscience Research Australia, Randwick, New South Wales, Australia
Matthew C. Kiernan
Affiliation:
Neuroscience Research Australia, Randwick, New South Wales, Australia Sydney Medical School, University of Sydney, Camperdown, New South Wales, Australia
*
Address correspondence and reprint requests to: Jashelle Caga, Neuroscience Research Australia, P.O. Box 1165, Randwick, NSW 2031, Australia. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Recognizing depressive symptoms in patients with amyotrophic lateral sclerosis (ALS) remains problematic given the potential overlap with the normal psychological responses to a terminal illness. Understanding mental health and disease-related risk factors for depression is key to identifying psychological morbidity. The present study aimed to determine the prevalence of depressive symptoms in ALS and to explore mental health and disease-related risk factors for depression.

Method:

Structured medical and psychiatric history questionnaires and a validated depression scale (Depression, Anxiety, Stress Scale–21) were completed by 27 ALS patients (60% female; 59% limb onset; age 65.11 ± SE 2.21) prior to their initial review at a multidisciplinary clinic. Physical function was assessed with the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS–R).

Results:

At the time of initial assessment, 44% of patients had a previous psychiatric history, although the majority (62%) reported no symptoms of depression. The mean ALSFRS–R score was 37.78 ± SE 1.22, with an average diagnostic interval of 16.04 ± SE 2.39 months. Logistic regression analysis revealed that the length of the diagnostic interval alone predicted depressive symptoms (χ2(3, n = 26) = 9.21, Odds Ratio (OR) = 1.12, p < 0.05.

Significance of Results:

The illness experiences of ALS patients rather than established mental health risk factors influence the manifestation of depressive symptoms in the early stages of the disease, with clinical implications for the assessment and treatment of psychological morbidity. Patients with lengthy diagnostic intervals may be prime targets for psychological assessment and intervention, especially in the absence of ALS-specific tests and biomarkers.

Keywords

Amyotrophic lateral sclerosisDepressionRisk factorsDiagnostic intervalGrief
Type
Original Articles
Information
Palliative & Supportive Care , Volume 13 , Issue 4 , August 2015 , pp. 1019 - 1024
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders, 4th ed., revised [DSM–IV–TR]. Washington, DC: APA Google Scholar
Atassi, N., Cook, A., Pineda, C.M., et al. (2011). Depression in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 12, 109–112.CrossRefGoogle ScholarPubMed
Averill, A.J., Kasarskis, E.J. & Segerstrom, S.C. (2007). Psychological health in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 8, 243–254.CrossRefGoogle ScholarPubMed
Brooks, B.R., Miller, R.G., Swash, M., et al. (2000). El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 1, 293–299.CrossRefGoogle Scholar
Bungener, C., Piquard, A., Pradat, P.F., et al. (2005). Psychopathology in amyotrophic lateral sclerosis: A preliminary study with 27 ALS patients. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 6, 221–225.Google Scholar
Cedarbaum, J.M., Stambler, N., Malta, E., et al. (1999). The ALSFRS–R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). Journal of the Neurological Sciences, 169, 13–21.Google Scholar
Clarke, D.M., McLeod, J.E., Smith, G.C., et al. (2005). A comparison of psychosocial and physical functioning in patients with motor neuron disease and metastatic cancer. Journal of Palliative Care, 21, 173–179.Google Scholar
Clarke, S., Hickey, A., O'Boyle, C., et al. (2001). Assessing individual quality of life in amyotrophic lateral sclerosis. Quality of Life Research, 10, 149–158.CrossRefGoogle ScholarPubMed
Ferentinos, P., Paparrigopoulos, T., Rentzos, M., et al. (2011). Prevalence of major depression in ALS: Comparison of a semistructured interview and four self-report measures. Amyotrophic Lateral Sclerosis, 12, 297–302.Google Scholar
Ganzini, L., Johnston, W.S. & Hoffman, W.F. (1999). Correlates of suffering in amyotrophic lateral sclerosis. Neurology, 52, 1434–1440.CrossRefGoogle ScholarPubMed
Gauthier, A., Vignola, A., Calvo, A., et al. (2007). A longitudinal study on quality of life and depression in ALS patient–caregiver couples. Neurology, 68, 923–926.Google Scholar
Goldstein, L.H., Atkins, L., Landau, S., et al. (2006). Longitudinal predictors of psychological distress and self-esteem in people with ALS. Neurology, 67, 1652–1658.CrossRefGoogle ScholarPubMed
Grehl, T., Rupp, M., Budde, P., et al. (2011). Depression and QoL in patients with ALS: How do self-ratings and ratings by relatives differ? Quality of Life Research, 20, 569–574.CrossRefGoogle ScholarPubMed
Hammer, E.M., Hacker, S., Hautzinger, M., et al. (2008). Validity of the ALS–Depression Inventory (ADI–12): A new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis. Journal of Affective Disorders, 109, 213–219.CrossRefGoogle ScholarPubMed
Hardiman, O., van den Berg, L.H. & Kiernan, M.C. (2011). Clinical diagnosis and management of amyotrophic lateral sclerosis. Nature Reviews. Neurology, 7, 639–649.Google Scholar
Hillemacher, T., Grassel, E., Tigges, S., et al. (2004). Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 5, 245–249.Google Scholar
IBM (2012). IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM.Google Scholar
Kiernan, M.C., Vucic, S., Cheah, B.C., et al. (2011). Amyotrophic lateral sclerosis. Lancet, 377, 942–955.CrossRefGoogle ScholarPubMed
Kubler, A., Winter, S., Ludolph, A.C., et al. (2005). Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabilitation and Neural Repair, 19, 182–193.Google Scholar
Kubler-Ross, E. (1969). On death and dying. New York: Macmillan.Google Scholar
Leigh, P., Abrahams, S., Al-Chalabi, A., et al. (2003). The management of motor neuron disease. Journal of NeurologyNeurosurgeryand Psychiatry, 74, iv32–iv47.Google Scholar
Lillo, P., Mioshi, E., Burrell, J.R., et al. (2012 a). Grey and white matter changes across the amyotrophic lateral sclerosis–frontotemporal dementia continuum. PLoS One, 7, e43993.Google Scholar
Lillo, P., Savage, S., Mioshi, E., et al. (2012 b). Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum. Amyotrophic Lateral Sclerosis, 13, 102–109.CrossRefGoogle ScholarPubMed
Lovibond, S.H. & Lovibond, P.F. (1995). Manual for the depression anxiety stress scales. Sydney$ Psychology Foundation.Google Scholar
Lule, D., Hacker, S., Ludolph, A., et al. (2008). Depression and quality of life in patients with amyotrophic lateral sclerosis. Deutsches Ärzteblatt International, 105, 397–403.Google ScholarPubMed
Matuz, T., Birbaumer, N., Hautzinger, M., et al. (2010). Coping with amyotrophic lateral sclerosis: An integrative view. Journal of Neurology, Neurosurgery, and Psychiatry, 81, 893–898.Google Scholar
McElhiney, M.C., Rabkin, J.G., Gordon, P.H., et al. (2009). Prevalence of fatigue and depression in ALS patients and change over time. Journal of Neurology, Neurosurgery, and Psychiatry, 80, 1146–1149.Google Scholar
McLeod, J.E. & Clarke, D.M. (2007). A review of psychosocial aspects of motor neurone disease. Journal of the Neurological Sciences, 258, 4–10.Google Scholar
Mioshi, E., Dawson, K., Mitchell, J., et al. (2006). The Addenbrooke's Cognitive Examination Revised (ACE–R): A brief cognitive test battery for dementia screening. International Journal of Geriatric Psychiatry, 21, 1078–1085.Google Scholar
Mioshi, E., Lillo, P., Yew, B., et al. (2013). Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes. Neurology, 80, 1117–1123.Google Scholar
Norris, L., Que, G. & Bayat, E. (2010). Psychiatric aspects of amyotrophic lateral sclerosis (ALS). Current Psychiatry Reports, 12, 239–245.Google Scholar
O'Brien, M.R., Whitehead, B., Jack, B.A., et al. (2011). From symptom onset to a diagnosis of amyotrophic lateral sclerosis/motor neuron disease (ALS/MND): Experiences of people with ALS/MND and family carers. A qualitative study. Amyotrophic Lateral Sclerosis, 12, 97–104.CrossRefGoogle ScholarPubMed
Oh, H., Sin, M.K., Schepp, K.G., et al. (2012). Depressive symptoms and functional impairment among amyotrophic lateral sclerosis patients in South Korea. Rehabilitation Nursing, 37, 136–144.Google Scholar
Periyakoil, V.S. & Hallenbeck, J. (2002). Identifying and managing preparatory grief and depression at the end of life. American Family Physician, 65, 883–890.Google Scholar
Rabkin, J.G., Albert, S.M., Del Bene, M.L., et al. (2005). Prevalence of depressive disorders and change over time in late-stage ALS. Neurology, 65, 62–67.Google Scholar
Simmons, Z., Bremer, B.A., Robbins, R.A., et al. (2000). Quality of life in ALS depends on factors other than strength and physical function. Neurology, 55, 388–392.Google Scholar
Taylor, S.E. (2006). Psychological issues in advancing and terminal illness. Health Psychology, 6, 315–340.Google Scholar
Traynor, B.J., Alexander, M., Corr, B., et al. (2003). Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: A population-based study, 1996–2000. Journal of Neurology, Neurosurgery, and Psychiatry, 74, 1258–1261.Google Scholar
Turner, M.R., Hardiman, O., Benatar, M., et al. (2013). Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurology, 12, 310–322.Google Scholar
van den Berg, J.P., Kalmijn, S., Lindeman, E. et al. (2005). Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology, 65, 1264–1267.CrossRefGoogle ScholarPubMed
van Egeren, L.K. (2004). Assessment approaches in health psychology: Issues and practical considerations. In Clinical handbook of health psychology: A practical guide to effective interventions. Camic, P.M. & Knight, S.J. (ed.), Vol. 2, pp. 11–26. Kirkland, WA: Hogrefe & Huber.Google Scholar
Vignola, A., Guzzo, A., Calvo, A., et al. (2008). Anxiety undermines quality of life in ALS patients and caregivers. European Journal of Neurology, 15, 1231–1236.Google Scholar
Winhammar, J.M., Rowe, D.B., Henderson, R.D., et al. (2005). Assessment of disease progression in motor neuron disease. Lancet Neurology, 4, 229–238.CrossRefGoogle ScholarPubMed